Bioequivalence studies Nipezam retard tablets, 400 mg (JSC «Himfarm», Kazakhstan) and Finlepsin® 400 retard tablets 400 mg («Pliva Krakow, SA Pharmaceutical company», Poland)

• Main Authors: A. K. Sariev (Author), D. A. Abaimov (Author), M. V. Tankevich (Author), Y. . Budach (Author), O. . Kurilov (Author), S. A. Altinbekov (Author), G. A. Dzholdygulov (Author), V. N. Seryakov (Author), K. S. Altinbekov (Author)
• Format: Book
• Published: LLC "Publisher OKI", 2014-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In a single-dose, two-treatment, two-period, two-sequence crossover study with a 1-month washout period was carry out the bioequivalence study of two tablet coated formulation of carbamazepine that given to 18 volunteers in equal doses (400 mg). Drug blood plasma concentrations were determined by va...